Back to companies
REGENTIS BIOMATERIALS LTD.
RGNTILNYSEPharmaceuticals & HealthcareREGENTIS BIOMATERIALS LTD.
Revenue
—
FY2025
Operating income
-$7.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API